ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double-Blind, Multi-Center Phase 3 Trial
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Breelyn Wilky](https://som.ucdenver.edu/FIMS/Content/faculty/28739/CU-Doctors-28739.jpg)
Breelyn Wilky
Study ID
Protocol Number: 23-1728
More information available at ClinicalTrials.gov: NCT05712694
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers